✦ LIBER ✦

Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

✍ Scribed by D Santini; F Graziano; V Catalano; M Di Seri; E Testa; AM Baldelli; P Giordani; A La Cesa; B Spalletta; B Vincenzi; A Russo; M Caraglia; V Virzi; S Cascinu; G Tonini

Book ID: 115010770
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 281 KB
Volume: 6
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-6-125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of biweekly oxaliplatin

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

✍ De Vita, F; Orditura, M; Matano, E; Bianco, R; Carlomagno, C; Infusino, S; Damia 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as first-line treatment for advanced colorectal cancer: A Japanese experience

✍ Hideo Baba; Naoko Hayashi; Yasunori Emi; Yoshihiro Kakeji; Akinori Egashira; Eij 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 143 KB

A phase II study of capecitabine plus 3-

A phase II study of capecitabine plus 3-weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer

✍ Park, Y H; Kim, B-S; Ryoo, B-Y; Yang, S H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

A randomized phase II study of weekly do

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer

✍ Kim, Young Saing; Sym, Sun Jin; Park, Se Hoon; Park, Inkeun; Hong, Junshik; Ahn, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 201 KB

Sequential chemotherapy with dose-dense

Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial

✍ Matteo Dalla Chiesa; Gianluca Tomasello; Sebastiano Buti; Rodrigo Kraft Rovere; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 277 KB

Weekly 5-fluorouracil and high-dose foli

Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study

✍ Herbert Stöger, Thomas Bauerhofer… 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 415 KB